Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis.

"Disclosure A.M. declares teaching and speaking and research support: Angelini, Gilead Sciences, Polifarma. F.F and C.H are employees of Gilead Sciences. M.P. reports grants, personal fees, non-financial support from Gilead, AbbVie; personal fees from Merck, during the conduct of the study; personal fees from Angelini, Astra Zeneca, GSK, Menarini, Janssen, Roche, and Novartis, outside the submitted work. All other authors report no conflicts of interest in this work."

"Gilead purchased the study report that is the basis for this manuscript. This manuscript was developed with Gilead and CliCon S.r.l. Società Benefit. The views expressed here are those of the authors and not necessarily those of the supporters. The agreement signed by CliCon S.r.l. Società Benefit and Gilead does not create any entityship, joint venture, or any similar relationship between parties. CliCon S.r.l. Società Benefit is an independent company. Neither CliCon S.r.l. Società Benefit nor any of their representatives are employees of Gilead for any purpose."